CAR-T Referral Process: Insights from UCSF : Episode 4
Referral Process for CAR T-Cell Therapy: Initial Contact Through Patient Evaluation and Selection
Panelists discuss how the typical CAR T-cell therapy referral process begins with community physicians contacting the treatment center. The patient undergoes a thorough evaluation, including medical history, eligibility criteria, and pretreatment assessments before final selection for therapy.
EP: 1.Introduction and CAR-T Therapy in Earlier Lines of Treatment for R/R Multiple Myeloma
EP: 2.Decision Points for Using CAR T-Cell Therapy in Early Lines of Treatment
EP: 3.Second-Line Treatment for R/R Multiple Myeloma: Who Is the “Right Patient”?
Now Viewing
EP: 4.Referral Process for CAR T-Cell Therapy: Initial Contact Through Patient Evaluation and Selection
EP: 5.CAR T-Cell Therapy: CAR T-Cell therapy Process and Bridging Therapy
EP: 6.Care Coordination and Transition Strategies for CAR -T Therapy
EP: 7.CAR -T Therapy in Early Lines of R/R MM: Clinical Scenario Discussion and Key Takeaways
EP: 8.Key Takeaways in CAR-T Therapy for Multiple Myeloma
Video content above is prompted by the following:
- Walk us through the typical CAR T referral process at your institution––from the initial community physician outreach to the patient evaluation and selection.
Recent Videos
Related Content
